Abnormal expression of Pygopus 2 correlates with a malignant phenotype in human lung cancer

BMC Cancer

Table 1 Pygo2 expression correlates with specific clinicopathological factors of lung cancer

Clinicopathological factors	n	Abnormal expression	Pvalue
Age
≤ 60 years	71	50 (70.42%)	0.638
> 60 years	97	65 (67.01%)
Gender
Male	107	76 (71.03%)	0.341
Female	61	39 (63.93%)
Histology
SCC	72	49 (68.06%)	0.924
Adenocarcinoma	96	66 (68.75%)
Differentiation
Well	66	38 (57.58%)	0.015
Moderate–poor	102	77 (75.49%)
TNM stage
I–II	95	58 (61.05%)	0.019
III	73	57 (78.08%)
Lymphatic metastasis
No	94	59 (62.77%)	0.074
Yes	74	56 (75.68%)

ISSN: 1471-2407